syncytial


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to syncytial: respiratory syncytial virus

syn·cy·tial

(sin-si'shăl, -sish'ē-ăl, -sit'ē-ăl),
Relating to a syncytium.

syncytial

/syn·cy·tial/ (sin-sish´al) of or pertaining to a syncytium.

syncytial

[sinsish′əl]
pertaining to a syncytium.

syn·cy·tial

(sin-sish'ăl)
Relating to a syncytium.

syncytial

pertaining to or producing a syncytium.

bovine syncytial virus
feline syncytial virus
syncytial giant cell
multinucleated mass of protoplasm formed by the fusion of a number of cells; a stage in the formation of a syncytium.
References in periodicals archive ?
He said that Respiratory syncytial virus (RSV), is highly contagious, and spreads through droplets containing the virus when someone coughs or sneezes.
The company's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza, respiratory syncytial virus, Strep A, herpes, pregnancy, thyroid disease and fecal occult blood.
The report provides a snapshot of the global therapeutic landscape of Respiratory Syncytial Virus (RSV) Infections
The report reviews key players involved in the therapeutics development for Respiratory Syncytial Virus (RSV) Infections and enlists all their major and minor projects
Syncytial knots were found in all placentas but they were considerably more at decreasing levels of maternal hemoglobin (19.
Mardi K, Sharma J (2003) (2) suggested that there is highly significant increase in the incidence of infarction, intervillous fibrin deposition, stromal fibrosis and syncytial knotting were found in IUGR placentas compared to full term normal placentas on microscopic examination.
Analysis of respiratory syncytial virus strain variation in successive epidemics in one city.
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
The FDA's Antiviral Drug Products Advisory Committee voted 14 to 3 against recommending approval of motavizumab for the indication proposed by its manufacturer, MedImmune LLC: the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease (premature infants, children with chronic lung disease of prematurity, and children with hemodynamically significant congenital heart disease).